The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,401–5,500 of 31,469
Carboxylation of Osteocalcin Affects Its Association With Metabolic Parameters in Healthy Children
Prats‐Puig, A., Mas‐Parareda, M., Riera-Pérez, E., González-Forcadell, D., Mier, C., Mallol-Guisset, M., Díaz, M., Bassols, J., de Zegher, F., Ibáñez, L., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1837 · Cited by 64
Samaras, K. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm475 · Cited by 65
Hafizur, R. M., Kabir, N., & Chishti, S. (2011) · Natural Product Research · doi:10.1080/14786411003766904 · Cited by 66
Kebapçılar, L., Taner, C. E., Kebapçılar, A. G., & Sarı, İ. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0884-0 · Cited by 65
Genç, H., Doğru, T., Kara, M., Tapan, S., Erçin, C. N., Açıkel, C., Karslıoğlu, Y., & Bağcı, S. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31338-9 · Cited by 66
Derosa, G., Carbone, A., Franzetti, I., Querci, F., Fogari, E., Bianchi, L., Bonaventura, A., Romano, D., Cicero, A. F. G., & Maffioli, P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.05.022 · Cited by 68
Bergersen, B. M., Schumacher, A., Sandvik, L., Bruun, J. N., & Birkeland, K. I. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500361302 · Cited by 66
Can, A. S., Bersot, T. P., & Gönen, M. (2008) · Public Health Nutrition · doi:10.1017/s1368980008002474 · Cited by 65
Campagnoli, C., Pasanisi, P., Abbà, C., Ambroggio, S., Biglia, N., Brucato, T., Colombero, R., Danese, S., Donadio, M., Venturelli, E., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.004 · Cited by 66
Beydoun, M. A., Boueiz, A. R., Shroff, M. R., Beydoun, H. A., Wang, Y., & Zonderman, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0410 · Cited by 64
Suzuki, H., Fukushima, M., Usami, M., Ikeda, M., Taniguchi, A., Nakai, Y., Matsuura, T., Kuroe, A., Yasuda, K., Kurose, T., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1211 · Cited by 65
Tapia, E., Cristóbal, M., García‐Arroyo, F. E., Soto, V., Monroy-Sánchez, F., Pacheco, U., Lanaspa, M. A., Roncal-Jiménez, C. A., Cruz‐Robles, D., Ishimoto, T., et al. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00485.2012 · Cited by 67
Harrington, J. M., Dahly, D. L., Fitzgerald, T., Gilthorpe, M. S., & Perry, I. J. (2014) · Public Health Nutrition · doi:10.1017/s1368980014000111 · Cited by 70
Hadad, N., Burgazliev, O., Elgazar-Carmon, V., Solomonov, Y., Wueest, S., Item, F., Konrad, D., Rudich, A., & Lévy, R. (2013) · Diabetes · doi:10.2337/db12-1300 · Cited by 66
Kralisch, S., Tönjes, A., Krause, K., Richter, J., Lössner, U., Kovacs, P. L., Ebert, T., Blüher, M., Stümvoll, M., & Faßhauer, M. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0367 · Cited by 64
Leow, M. K., Griva, K., Choo, R. W. M., Wee, H. L., Thumboo, J., Tai, E. S., & Newman, S. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067138 · Cited by 66
Pijl, H., de Meijer, P. H. E. M., Langius, J. A. E., Coenegracht, C. I. G. M., Berk, A., Shaw, P. K. C., Boom, H., Schoemaker, R. C., Cohen, A., Burggraaf, J., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8112 · Cited by 66
Changes in inflammatory biomarkers after successful lifestyle intervention in obese children.
Garanty‐Bogacka, B., Syrenicz, M., Goral, J., Krupa, B., Syrenicz, J., Walczak, M., & Syrenicz, A. (2011) · PubMed · Cited by 65
Plasma Aldosterone Levels and Development of Insulin Resistance
Kumagai, E., Adachi, H., Jacobs, D. R., Hirai, Y., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Nanjo, Y., Yoshikawa, K., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180521 · Cited by 67
Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., Cupples, L. A., Ordovás, J. M., Defoort, C., Lovegrove, J. A., Drevon, C. A., Gibney, M. J., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003046 · Cited by 67
IL-6 Promoter Polymorphism −174 Is Associated with New-Onset Diabetes after Transplantation
Bamoulid, J., Courivaud, C., Deschamps, M., Mercier, P., Ferrand, C., Penfornis, A., Tiberghien, P., Chalopin, J., Saas, P., & Ducloux, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010066 · Cited by 65
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children
Koren, D., Gozal, D., Philby, M. F., Bhattacharjee, R., & Gozal, D. (2016) · European Respiratory Journal · doi:10.1183/13993003.01430-2015 · Cited by 67
Zeba, A. N., Delisle, H. F., & Renier, G. (2014) · Journal of Nutritional Science · doi:10.1017/jns.2014.11 · Cited by 65
Derosa, G., Cicero, A. F. G., D’Angelo, A., Borghi, C., & Maffioli, P. (2016) · BioFactors · doi:10.1002/biof.1277 · Cited by 66
Choi, S. I., Chung, D., Lim, J. S., Lee, M. Y., Shin, J. Y., Chung, C. H., & Huh, J. H. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.1.51 · Cited by 67
Ginés, C., Cuesta‐Sancho, S., Kireev, R. A., Garcı́a, C., Rancán, L., Paredes, S. D., Vara, E., & Tresguerres, J. A. F. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.01.021 · Cited by 66
Brain changes in overweight/obese and normal-weight adults with type 2 diabetes mellitus
Yoon, S. J., Cho, H., Kim, J., Lee, D.-W., Kim, G. H., Hong, Y. S., Moon, S., Park, S., Lee, S., Lee, S. L., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4266-7 · Cited by 70
Effoe, V. S., Carnethon, M. R., Echouffo-Tcheugui, J. B., Chen, H., Joseph, J. J., Norwood, A. F., & Bertoni, A. G. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005008 · Cited by 65
Airborne PM2.5-Induced Hepatic Insulin Resistance by Nrf2/JNK-Mediated Signaling Pathway
Xu, J., Zhang, W., Lu, Z., Zhang, F., & Ding, W. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14070787 · Cited by 64
Sleep Deprivation Selectively Upregulates an Amygdala–Hypothalamic Circuit Involved in Food Reward
Rihm, J. S., Menz, M. M., Schultz, H., Bruder, L. R., Schilbach, L., Schmid, S. M., & Peters, J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0250-18.2018 · Cited by 69
Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
Nowak, C., Hetty, S., Salihović, S., Castillejo-López, C., Ganna, A., Cook, N. L., Broeckling, C. D., Prenni, J. E., Shen, X., Giedraitis, V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26701-0 · Cited by 70
The Association of Adiponectin and Visceral Fat with Insulin Resistance and β-Cell Dysfunction
Moon, H. U., Ha, K. H., Han, S. J., Kim, H. J., & Kim, D. J. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e7 · Cited by 68
Ku, E. J., Lee, D., Jeon, H. J., & Oh, T. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.008 · Cited by 65
Chu, W., Zhai, J., Xu, J., Li, S., Li, W., Chen, Z., & Du, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03145 · Cited by 67
Zeuzem, S., Sulkowski, M., Lawitz, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.066 · Cited by 65
Insulin resistance in obesity can be reliably identified from fasting plasma insulin
ter Horst, K. W., Gilijamse, P. W., Koopman, K. E., de Weijer, B. A., Brands, M., Kootte, R. S., Romijn, J. A., Ackermans, M. T., Nieuwdorp, M., Soeters, M. R., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.125 · Cited by 65
Association of Insulin Gene VNTR Polymorphism with Polycystic Ovary Syndrome
Vaňková, M., Vrbíková, J., Hill, M., Cinek, O., & Bendlová, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04317.x · Cited by 65
Low Ghrelin Concentrations in Nonalcoholic Fatty Liver Disease Are Related to Insulin Resistance
Marchesini, G., Pagotto, U., Bugianesi, E., Iasio, R. D., Manini, R., Vanni, E., Pasquali, R., Melchionda, N., & Rizzetto, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031094 · Cited by 64
Chang, A. M., Smith, M. J., Bloem, C. J., Gałecki, A. T., Halter, J. B., & Supiano, M. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1803 · Cited by 66
Increased insulin resistance and β cell activity in patients with Crohnʼs disease
Bregenzer, N., Hartmann, A., Strauch, U., Schölmerich, J., Andus, T., & Bollheimer, C. L. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195975.97673.f5 · Cited by 66
Kubaszek, A., Markkanen, A., Eriksson, J. G., Forsén, T., Osmond, C., Barker, D. J., & Laakso, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031350 · Cited by 64
Godsland, I., Crook, D., Proudler, A., & Stevenson, J. (2005) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2004-1292 · Cited by 70
Jaziri, R., Lobbens, S., Aubert, R., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0676 · Cited by 65
Birth weight and the Metabolic Syndrome: thrifty phenotype or thrifty genotype?
Stern, M. P., Bartley, M., Duggirala, R., & Bradshaw, B. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(200003/04)16:2 · Cited by 65
Significant ethnic variation in total and free testosterone concentration
Heald, A. H., Ivison, F., Anderson, S. G., Cruickshank, K. J., Laing, I., & Gibson, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01653.x · Cited by 64
Decreased β-Cell Function in Overweight Latino Children With Impaired Fasting Glucose
Weigensberg, M. J., Ball, G. D. C., Shaibi, G. Q., Cruz, M. L., & Goran, M. I. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2519 · Cited by 65
Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy
Hatano, H., Miller, K. D., Yoder, C. P., Yanovski, J. A., Sebring, N. G., Jones, E. C., & Davey, R. T. (2000) · AIDS · doi:10.1097/00002030-200009080-00008 · Cited by 65
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63
Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016) · Diabetes Care · doi:10.2337/dc16-0043 · Cited by 64
Honsek, C., Kabisch, S., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Dambeck, U., Osterhoff, M. A., Weickert, M. O., & Pfeiffer, A. F. H. (2018) · Diabetologia · doi:10.1007/s00125-018-4582-6 · Cited by 63
Snehalatha, C., Mary, S., Selvam, S., Sathish Kumar, C. K., Shetty, S. B. A., Nanditha, A., & Ramachandran, A. (2009) · Diabetes Care · doi:10.2337/dc09-0676 · Cited by 64
Rutter, M. K., Wilson, P. W. F., Sullivan, L. M., Fox, C. S., D’Agostino, R. B., & Meigs, J. B. (2008) · Circulation · doi:10.1161/circulationaha.107.727727 · Cited by 64
Küme, T., Acar, S., Tuhan, H., Çatlı, G., Anık, A., Gürsoy Çalan, Ö., Böber, E., & Abacı, A. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3682 · Cited by 64
Pandey, S. P., Singh, H. K., & Prasad, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131862 · Cited by 64
Oh, S., Tsujimoto, T., Kim, B., Uchida, F., Suzuki, H., Iizumi, S., Isobe, T., Sakae, T., Tanaka, K., & Shoda, J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100253 · Cited by 77
Swellam, M. M., & Hamdy, N. Μ. (2012) · IUBMB Life · doi:10.1002/iub.597 · Cited by 65
Metabolic pathways link childhood adversity to elevated blood pressure in midlife adults
Crowell, J. A., Davis, C. R., Joung, K. E., Usher, N., McCormick, S.-P., Dearing, E., & Mantzoros, C. S. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.10.009 · Cited by 66
A “systems medicine” approach to the study of non-alcoholic fatty liver disease
Petta, S., Valenti, L. V. C., Bugianesi, E., Targher, G., Bellentani, S., Bonino, F., Ferrannini, E., Loguercio, C., Lonardo, A., Marra, F., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.027 · Cited by 66
Cazzo, E., Pareja, J. C., Chaim, É. A., Geloneze, B., Barreto, M. R. L., & Magro, D. O. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2345-3 · Cited by 66
Benzene Exposure Induces Insulin Resistance in Mice
Abplanalp, W. T., Wickramasinghe, N. S. M. D., Sithu, S. D., Conklin, D. J., Xie, Z., Bhatnagar, A., Srivastava, S., & O’Toole, T. E. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy252 · Cited by 64
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
Araki, K., Araki, A., Honda, D., Izumoto, T., Hashizume, A., Hijikata, Y., Yamada, S., Iguchi, Y., Hara, A., Ikumi, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124481 · Cited by 64
Carvalho, G. C. N., Neto, J. C. G. L., de Araújo, M. F. M., et al. (2020) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.3870.3369 · Cited by 64
Klaver, M., van Velzen, D. M., de Blok, C. J. M., Nota, N. M., Wiepjes, C. M., Defreyne, J., Schreiner, T., Fisher, A. D., Twisk, J. W. R., Seidell, J. C., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab616 · Cited by 68
Luukkonen, P. K., Sakuma, I., Gaspar, R. C., Mooring, M., Nasiri, A. R., Kahn, M., Zhang, X., Zhang, D., Sammalkorpi, H. E., Penttilä, A. K., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217543120 · Cited by 73
Calorie restriction reduces biomarkers of cellular senescence in humans
Aversa, Z., White, T. A., Heeren, A. A., Hulshizer, C. A., Saul, D., Zhang, X., Molina, A. J. A., Redman, L. M., Martin, C. K., Racette, S. B., et al. (2023) · Aging Cell · doi:10.1111/acel.14038 · Cited by 66
García-Vicencio, S., Coudeyre, E., Kluka, V., Cardenoux, C., Jegu, A.-G., Fourot, A.-V., Ratel, S., & Martin, V. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.158 · Cited by 64
Yabe, D., Watanabe, K., Sugawara, K., Kuwata, H., Kitamoto, Y., Sugizaki, K., Fujiwara, S., Hishizawa, M., Hyo, T., Kuwabara, K., et al. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00141.x · Cited by 64
Reverri, E. J., Randolph, J., Steinberg, F. M., Kappagoda, C., Edirisinghe, I., & Burton‐Freeman, B. M. (2015) · Nutrients · doi:10.3390/nu7085273 · Cited by 72
Solak, Y., Yılmaz, M. İ., Sağlam, M., et al. (2013) · Nephrology · doi:10.1111/nep.12130 · Cited by 64
Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis
Yuan, J., Baker, S. S., Liu, W., Alkhouri, R. H., Baker, R. D., Xie, J., Ji, G., & Zhu, L. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12510 · Cited by 64
Chen, L., Li, Q., Yang, Z., Ye, Z., Huang, Y., He, M., Wen, J., Wang, X., Lü, B., Hu, J., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03769.x · Cited by 64
Serum Autotaxin/ ENPP 2 correlates with insulin resistance in older humans with obesity
Reeves, V. L., Trybula, J. S., Wills, R. C., Goodpaster, B. H., Dubé, J. J., Kienesberger, P. C., & Kershaw, E. E. (2015) · Obesity · doi:10.1002/oby.21232 · Cited by 64
Taniguchi, A., Fukushima, M., Seino, Y., Sakai, M., Yoshii, S., Nagasaka, S., Yamauchi, I., Okumura, T., Nin, K., Tokuyama, K., et al. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00099-4 · Cited by 64
Zaitone, S. A., Hassan, N., El-Orabi, N. F., & El‐Awady, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.049 · Cited by 64
Yoshinaga, H., & Kosáka, K. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00019-4 · Cited by 64
Effects of Aerobic Exercise on Microalbuminuria and Enzymuria in Type 2 Diabetic Patients
Lazarević, G., Antić, S., Vlahović, P., et al. (2007) · Renal Failure · doi:10.1080/08860220601098870 · Cited by 64
Determination of early urinary renal injury markers in obese children
Göknar, N., Öktem, F., Özgen, İ. T., Torun, E., Küçükkoç, M., Demir, A. D., & Cesur, Y. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2829-0 · Cited by 65
Chiba, M., Suzuki, S., Hinokio, Y., Hirai, M., Sato, Y., Tashiro, A., Utsumi, A., Awata, T., Hongo, M., & Toyota, T. (2000) · Metabolism · doi:10.1053/meta.2000.8611 · Cited by 64
miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease
Xu, Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.511 · Cited by 63
Tang, T. H., Glanville, J., Hayden, C. J., White, D. M., Barth, J. H., & Balen, A. H. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197800.07214.dc · Cited by 65
Tan, B. K., Chen, J., Digby, J. E., Keay, S. D., Kennedy, C. R., & Randeva, H. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0419-9 · Cited by 64
Lidder, P. G., Thomas, S., Fleming, S., Hosie, K. B., Shaw, S. R., & Lewis, S. J. (2013) · Colorectal Disease · doi:10.1111/codi.12130 · Cited by 64
Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study
Ebbesson, S. O. E., Tejero, M. E., Nobmann, E. D., López-Alvarenga, J. C., Ebbesson, L. O. E., Romenesko, T., Carter, E. A., Resnick, H. E., Devereux, R. B., MacCluer, J. W., et al. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.07393.x · Cited by 64
Chae, J. S., Paik, J. K., Kang, R., Kim, M., Choi, Y., Lee, S., & Lee, J. H. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.01.005 · Cited by 64
Are the reductions in triacylglycerol and insulin levels after exercise related?
Gill, J. M. R., Herd, S. L., TSETSONIS, N. V., & Hardman, A. E. (2002) · Clinical Science · doi:10.1042/cs1020223 · Cited by 63
Verit, F. F., & Erel, Ö. (2008) · Gynecologic and Obstetric Investigation · doi:10.1159/000113046 · Cited by 64
Cardiometabolic Risk Clustering in Spinal Cord Injury: Results of Exploratory Factor Analysis
Libin, A., Tinsley, E. A., Nash, M. S., Mendez, A. J., Burns, P. A., Elrod, M., Hamm, L. F., & Groah, S. L. (2013) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1903-183 · Cited by 64
Faeh, D., William, J., Tappy, L., Ravussin, É., & Bovet, P. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-163 · Cited by 64
Zheng, Y., Wang, X.-H., Lai, M.-H., Yao, H., Liu, H., & Ma, H. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0429 · Cited by 68
Shah, A. D., Vittinghoff, E., Kandula, N. R., Srivastava, S., & Kanaya, A. M. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.10.013 · Cited by 64
Sasaki, Y., Suzuki, W., Shimada, T., Iizuka, S., Nakamura, S., Nagata, M., Fujimoto, M., Tsuneyama, K., HOKAO, R., Miyamoto, K., et al. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.07.017 · Cited by 64
Altered Cardiac Autonomic Function May Precede Insulin Resistance in Metabolic Syndrome
Chang, C., Yang, Y., Lu, F., Lin, T., Chen, J., Yeh, T. L., Wu, C., & Wu, J. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.07.031 · Cited by 62
Shen, H., Shahzad, G., Jawairia, M., Bostick, R. M., & Mustacchia, P. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12944 · Cited by 64
Kahl, K. G., Bester, M., Greggersen, W., Rudolf, S., DIBBELT, L., Stoeckelhuber, B. M., Gehl, H., Sipos, V., Hohagen, F., & Schweiger, U. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000160458.95955.f4 · Cited by 65
Cavallo, M. G., Sentinelli, F., Barchetta, I., Costantino, C., Incani, M., Perra, L., Capoccia, D., Romeo, S., Cossu, E., Leonetti, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051236 · Cited by 68
Clinical Status and Cardiovascular Risk Profile of Adults with a History of Juvenile Dermatomyositis
Eimer, M. J., Brickman, W. J., Seshadri, R. S., et al. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.05.015 · Cited by 64
Gobbo, L. C. D., Song, Y., Dannenbaum, D. A., Dewailly, É., & Egeland, G. M. (2010) · Journal of Nutrition · doi:10.3945/jn.110.129619 · Cited by 66
Güldiken, S., Demir, M., Arıkan, E., Turgut, B., Azcan, Ş., Gerenli, M., & Tuğrul, A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.12.019 · Cited by 64
Pardina, E., Baena‐Fustegueras, J. A., Llamas, R., Catalán, R., Galard, R., Lecube, A., Fort, J. M., Llobera, M., Allende, H., Vargas, V., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9827-5 · Cited by 67
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
